77.1 F
New York
Wednesday, June 16, 2021

Thermo Fisher Scientific [NYSE: TMO] To Purchase Mesa Biotech For Approx. $450M In Cash

Must read

VEON [NASDAQ: VEON] Announces Acquisition of AdTech in Russia

VEON Ltd disclosed that it has purchased a majority stake in OTM which is a technology platform for the automation and planning of...

MicroStrategy Decides to Sell $1B Stock With Plans To Buy More Bitcoin With Profit

Shares of MicroStrategy Incorporated skyrocketed 5.36% on Wednesday after the firm disclosed that it has decided to dump $1 billion worth of its...

Thailand SEC Forbids Crypto Exchanges from Listing Meme Tokens, NFTs, and More

Thailand SEC has made a new decision that forbids crypto exchanges to list meme tokens, NFTs, and many more. The decision to ban certain...

China’s Cryptocurrency Mining Crackdown Appears to be Widening

The cryptocurrency mining crackdown of China is continuously increasing. It has been seen that government departments in the province of Yunnan are gearing up...

Thermo fisher scientific inc [NYSE: TMO] revealed that the company has signed a definitive contract to purchase Mesa Biotech. Thermo will pay a value price of nearly $450 Million in cash for this transaction. Upon the completion of certain targets, TMO will pay an additional payment of $100 Million in cash according to the contract.

The molecular diagnostic company mesa has made a testing platform based on PCR, available to detect diseases. The Rapid point of care platform will be able to identify viruses such as SARS-CoV-2, Influenza A and B, RSV, and Strep A. The California-based company has currently 500 employees and generated $45million in revenue in 2020.

“The biotech’s platform will aid us in enhancing the accessibility of dependable molecular diagnostic at the point of care. Since the pandemic started, TMO has provided quick support to professionals combating covid from the frontlines. Additionally, Mesa’s rapid test addition complements our existing offerings greatly. Moreover, It will further enable us to meet the covid related testing demands of the market ”. Said Mark Stevenson EVP and COO of TMO

More articles

Latest article

Accenture [NYSE: ACN] and Salesforce to Aid ISDI to Reduce its Environmental Impact

Accenture plc and Salesforce have partnered with ISDI to provide aid to the Salesforce-authorized global coaching organization. The firms will evaluate their carbon...

Iconix Brand [NASDAQ: ICON] to be Acquired by Iconix Acquisition Corp

Iconix Brand Group, Inc. disclosed that it has inked an agreement and plan of merger with Iconix Acquisition Corp. Iconix Brand Group is...

Binance Cryptocurrency Exchange to Launch a New NFT Platform

The Binance cryptocurrency exchange will be introducing a new on-chain NFT platform called "Featured by Binance". Cryptocurrency exchange Binance is joining the race of...

El Salvador Passes Bill to Accept Bitcoin as Legal Tender

EI Salvador has become the first country in Central America to pass the bill to accept Bitcoin as legal tender. It has been disclosed...

Gaming Platform Xaya Teams Up with Popular Ethereum Scaling Solution Polygon

Blockchain Gaming platform Xaya has joined hands with popular Ethereum scaling solution Polygon. Xaya has partnered with Polygon to improve the scalability of its...

Why CynergisTek [CTEK] is Skyrocketing Today?

CynergisTek, Inc. skyrocketed 24.73% during the trading session of Wednesday. The positive performance of the firm indicated the positive sentiments of the investors...

GOL Linhas [NYSE: GOL] Announces Acquisition of MAP Transportes Aéreos

Gol Linhas Aereas Inteligentes S.A. disclosed that it has inked an agreement to buy MAP Transportes Aéreos Ltda. The firm's buying decision highlights...

Chinese Twitter ‘Weibo’ Start Crack Down on Multiple Crypto Influencer Accounts

Chinese social media platform Weibo has started a crackdown against the multiple crypto influencer accounts. It has been disclosed that at least dozens of...